Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:95699OMIM:613571E25.0
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormal metacarpophalangeal joint morphologyHP:0011911CamptodactylyHP:0012385Metatarsal synostosisHP:0001440Metacarpal synostosisHP:0009701Rocker bottom footHP:0001838Humeroradial synostosisHP:0003041Proximal tibial and fibular fusionHP:0005892
Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

2 events
Dec 2026ENA-001 for Post Operative Respiratory Depression (PORD)

Enalare Therapeutics Inc. — PHASE2

TrialNOT YET RECRUITING
Jan 2020Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region

University of Minho

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency.

View clinical trials →

No actively recruiting trials found for Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency community →

Specialists

1 foundView all specialists →
OM
Ozge Bayrak Demirel, MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyForum →

No community posts yet. Be the first to share your experience with Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency.

Start the conversation →

Latest news about Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency

No recent news articles for Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency

Which specialists treat Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency?

1 specialists and care centers treating Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.